Survival of Mesenchymal Stem Cells in Different Methods of Nebulization
- 作者: Aver’yanov A.1, Konoplyannikov A.2, Antonov N.1, Osipova G.1, Vasil’eva O.1, Sakharova M.1, Tatarskii A.1, Kobylyansky V.1
-
隶属关系:
- Research Institute of Pulmonology, Federal Biomedical Agency
- National Medical Radiology Research Center, Ministry of Health of the Russian Federation
- 期: 卷 164, 编号 4 (2018)
- 页面: 576-578
- 栏目: Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)
- URL: https://journals.rcsi.science/0007-4888/article/view/239754
- DOI: https://doi.org/10.1007/s10517-018-4034-9
- ID: 239754
如何引用文章
详细
We compared survival of bone marrow mesenchymal stem cells after compressor, ultrasound, and mesh nebulization of the cell suspension over 10 min. Viability of stromal cells was best preserved after compressor nebulization (72%). Cell survival after ultrasonic nebulization was significantly lower (20%). After mesh nebulization, no live cells were found. Thus, compressor nebulization is the most preferable method of the production of cell aerosol for their delivery to the lower respiratory tract.
作者简介
A. Aver’yanov
Research Institute of Pulmonology, Federal Biomedical Agency
编辑信件的主要联系方式.
Email: averyanovav@mail.ru
俄罗斯联邦, Moscow
A. Konoplyannikov
National Medical Radiology Research Center, Ministry of Health of the Russian Federation
Email: averyanovav@mail.ru
俄罗斯联邦, Obninsk
N. Antonov
Research Institute of Pulmonology, Federal Biomedical Agency
Email: averyanovav@mail.ru
俄罗斯联邦, Moscow
G. Osipova
Research Institute of Pulmonology, Federal Biomedical Agency
Email: averyanovav@mail.ru
俄罗斯联邦, Moscow
O. Vasil’eva
Research Institute of Pulmonology, Federal Biomedical Agency
Email: averyanovav@mail.ru
俄罗斯联邦, Moscow
M. Sakharova
Research Institute of Pulmonology, Federal Biomedical Agency
Email: averyanovav@mail.ru
俄罗斯联邦, Moscow
A. Tatarskii
Research Institute of Pulmonology, Federal Biomedical Agency
Email: averyanovav@mail.ru
俄罗斯联邦, Moscow
V. Kobylyansky
Research Institute of Pulmonology, Federal Biomedical Agency
Email: averyanovav@mail.ru
俄罗斯联邦, Moscow